Dr. Xu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
Philadelphia, PA 19104Phone+1 215-662-6503
Education & Training
- Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Dermatopathology, 2001 - 2002
- University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 1997 - 2001
- Shandong Medical UniversityClass of 1992
Certifications & Licensure
- PA State Medical License 1998 - 2026
- NJ State Medical License 2022 - 2025
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Dermatopathology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- Divergent effects of acute and chronic PPT1 inhibition in melanoma.Mary Ann S Crissey, Amanda Versace, Monika Bhardwaj, Vaibhav Jain, Shujing Liu
Autophagy. 2025-02-01 - Programmed Death Ligand-1 in Melanoma and Extracellular Vesicles Promotes Local and Regional Immune Suppression through M2-like Macrophage Polarization.Lili Huang, Jingbo Yang, Jinjin Zhu, Huaishan Wang, Liyun Dong
The American Journal of Pathology. 2025-02-01 - Engineered extracellular vesicles with DR5 agonistic scFvs simultaneously target tumor and immunosuppressive stromal cells.Yeye Guo, Huaishan Wang, Shujing Liu, Xiaogang Zhang, Xingyue Zhu
Science Advances. 2025-01-17
Journal Articles
- Exosomal PD-L1 Contributes to Immunosuppression and Is Associated with Anti-PD-1 ResponseXiaowei Xu, Haidong Dong, Tara C Mitchell, Lynn M Schuchter, Alexander C Huang, Suzanne McGettigan, Wei Xu, Giorgos C Karakousis, Xiaoming Liu, Gordon Mills, Nature
- Pathological Assessment of Resection Specimens After Neoadjuvant Therapy for Metastatic MelanomaM T Tetzlaff, J E Gershenwald, X Xu, V G Prieto, T Mitchell, M A Davies, J M Taube, Annals of Oncology
- A Designer Cross-Reactive DNA Immunotherapeutic Vaccine That Targets Multiple MAGE-A Family Members Simultaneously for Cancer TherapyXiaoming Liu, Xiaowei Xu, Clinical Cancer Research
Press Mentions
- Small Extracellular Vesicles Could Pack a Punch Against Solid TumorsJanuary 21st, 2025
- 20 Years in the Making: Scientists Unveil Breakthrough Anticancer WeaponJanuary 20th, 2025
- HMN 2025: Scientists Develop a Tiny Weapon Against CancerJanuary 16th, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: